Immunization

Vaccine Name Oral polio (OPV)

Type of Vaccine Live virus

Starting Age Birth

Dose 2 drops for multidose vial 0.5 ml

No. of doses
3 doses and 2 boosters

Schedule 4,6,18 months & 5 to 6 years 2 months

Site Oral

Rou te Oral

Storage Temp 2-8 C

Contraindications In immunodeficiency, hypersensitivity and pregnancy -Hypersensitivity -Acute severe febrile illness -pregnancy -Convulsive or nonconvulsive active encephalopathy -Allergy and hypersensitivity -severe reaction to vaccine Hypersensitivity, encephalopathy

Indications Prevention of poliomyelitis

Injectable polio (IPV)

Inactivated virus

Birth

3 doses and 2 boosters

Thigh

IM

2-8 C

Prevention of poliomyelitis

Diphtheria/Tetanu/ acellular pertuss (DTaP)

-DT Toxoid
-P inactivated bacteria

2 months

0.5 ml

2nd
booster

5 to 6 years

Thigh

IM

2-8 C

Diphtheria/tetanu/ DT Toxoid Pertuss/Hemophilus P inactivated influenza b/Hepatitis B bacteria (Pentavalent)

Hib capsular polysaccharide HB inactivated virus

2 months

0.5 ml Powder and diluent

3 doses and one

booster

4,6,18 months

Thigh

IM

2-8 C

Diphtheria/Tetanus (D.T child)

Toxoid

2 months

0.5 ml

3 doses and 2
boosters

2,4,6,18 months and 5 to

Thigh

IM

2-8 C

Allergy to vaccine

Prevention of diphtheria, tetanus and pertussis in infants and children 2 months to 6 years of age Active immunization against diphtheria, tetanus, pertussis, hepatitis B and H. influenza type B Prevention of diphtheria, tetanus in

6 years

Tetanus/Diphtheria (Td Adult)

Toxoid

7 years

0.5 ml

3 doses and
booster

every 10 years

Measles, mumps, rubella (MMR)

Live virus

12 months

0.5 ml powder & diluent

2 doses

3 doses 4 weeks apart, Primary doses & a booster every 10 years 1 yr, 5-6 yrs, 12 yrs + postnatal (nonimmune)

Deltoid

IM

2-8 C

Allergy to the vaccine

children from 2 months 6 years when pertussis is contraindicated Prevention of diphtheria and tetanus in children above 7 years of age and adults

Thigh: child
Deltoid:

SC

2-8 C

adult

Hepatitis B child Hepatitis B adults

Inactivated virus Inactivated virus

Birth 10 years

0.5 ml (10 mcg) 1 ml (20 mcg)

3 doses 3 doses

Hepatitis A- Child

-Inactivated

-12

Accordin

-2

2,4,6 months Contacts of a case, Health care workers, 14 years at school, College students 12

Thigh
Deltoid

IM IM

2-8 C 2-8 C

Pregnancy/ sensitivity to neomycin, egg/ febrile illness/ Active T discraises/Bone marrow diseases, leukemia, lymphatic malignant diseases Acute severe febrile illness Acute severe febrile illness

Simultaneous immunization against measles, mumps and rubella

Infants and children Risk of exposure

Thigh

IM

2-8 C

-Acute severe febrile

For people

Adult

virus -Inactivated virus

months -19 years

g to the company

Meningococcal (ACYW)

Polysaccaride (inactivated bacteria)

2 years

0.5 ml powder & diluents

doses up to 18 years -2 doses 19 years 1 dose every 3 years

month; 24 month; 2 doses 1 year apart for 19 years 2 years of age, hajiis & travelers

(child)
Deltoid

(adult)

illness -Hypersensitivity to any component of the vaccine

exposed to risks of hepatitis A infection or contamination

Thighchild
Deltoid-

IM

2-8 C

adult

Severe acute febrile illness/pregnancy/ hypersensitivity to phenol

Typhoid

Inactivated bacteria

> 2 years

0.5 ml powder & diluent 0.5 ml powder & diluent

1 dose every 3 years 1 dose every 10 years

Yellow fever

Live virus

6 months

Influenza

Inactivated virus

>6 months

0.5 ml > 3 years of age, 0.25 ml < 3 years of age

1 dose every year beginning from June

Travelers to endemic countries Single dose every 10 years for travelers to endemic countries 36 months 6-35 months

Thighchild
Deltoid-

IM

2-8 C

Hypersensitivity

Close contacts of patient/ travelers to epidemic and endemic areas/ hajiis Protection of travelers against typhoid Prevention of yellow fever in travelers to endemic areas

adult Thighchild
Deltoid-

SC

2-8 C

adult

Allergy to egg/ infant below 6 months/ pregnancy/ immunodeficiency except HIV

Deltoid-

IM

2-8 C

adult Thighchild

Allergy to egg, neomycin

Prevention of flu virus infection in adults and children over 6 months of age, elderly (high risk groups)

Pneumococcal polysaccharide

Polysaccharide

2 years

0.5 ml

(inactivated bacteria )

2 doses for high risk group, 3

months

Single dose every 3 years

Thighchild
Deltoid-

IM

2-8 C

adult

apart

Fever/ acute disease (it is preferable to postpone vaccination)/ true allergy to one of the ingredients of the vaccine/ during first 3 months of pregnancy

Pneumococcal conjugate

Inactivated bacteria

2 months

0.5 ml

4 doses

2 months 4 months 6 months

12 months

Thigh

IM

2-8 C

If the child is allergic to the active substance, to any other ingredients or to diphtheria toxoid

Chicken pox

Live virus

12 months

0.5 ml

Single dose (child) 2 doses

Single dose 112 years, 2 doses

Thighchild
Deltoid-

SC

2-8 C

adult

Hypersensitivity to one of vaccine component/ Acute severe febrile

For children and adults at high risk of infection (prevention of pneumococcal infection for elderly, DM, chronic bronchitis, respiratory insufficiency, heart failure,tobacco/ alcohol dependency/ SCD) Protect the child against meningitis, bacteremia, bacteremic pneumonia/ high risk group/ Preventing otitis media or any other pneumococcal infection during first 2 years of life Active immunization against Varicella of healthy

13 years

13 years 6 weeks apart

illness/ systemic hypersensitivity/ pregnancy

BCG

Live bacteria

At birth

PPD test

Tuberculin purified protein derivative

Any age

Powder & diluent * < 1 yr 0.05 ml * 1 yr 0.1 ml 0.1 ml

1 dose

Newborn (NonBahraini)

Left
deltoid

Intra der mal

2-8 C

Immunodeficiency/ extensive progressive dermatitis

subjects 12 months from high risk pt & healthy close contacts of acute endemic illness Prevention of primary tuberculosis

When
needed

When needed

Left forearm

Intra derm al

2-8 C

Hypersensitivity

Rabies

Inactivated virus

Immediately after exposure

0.5 IU/ml 0.5 ml powder & diluent

5 doses

5 dose series on days 0, 3, 7, 14, 30

Thighchild
Deltoid-

IM

2-8 C

adult

PRE-EXPOSURE: severe febrile infection, acute disease, chronic disease, hypersensitivity, allergy to neomycin

(RIG) Rabies immunoglobulin (Human)

Immunoglobulin

Any age

20 IU/Kg of body weight

Single dose

Post exposure

dose local infilt infiltration rati

2-8 C

Live vaccines should be given at least 3 weeks before (RIG)

Diagnosis of TB infection, To determine whether a person has ever infected with Mycobacteria tuberculosis PRE-EXPOSURE: prevention of rabies at high risk people POSTEXPOSURE: after known or possible exposure to rabies Post-exposure treatment following

at bite site and the remainder -Thigh (child)

-Deltoid (adult) Deltoid-

on -IM

or not given until 3 months after RIG

suspected rabies contact

Hepatitis B immune globulin

Immune globulin

Any age

-Adult: 1,0002,000 IU -Children: 32-48 IU/kg

-Neonates:

-Single dose -Single dose

-1 dose +1 booster

100-200 IU

(2-3
months

after 1st dose)

-postexposure -in neonates of hepatitis B positive mothers within 12 hours

IM

2-8 C

Adult ThighChild and neonates

HBsAg positive individuals but in neonates regardless of testing result of HBsAg

For prophylaxis of hepatitis B after exposure to HBsAg